Last update 12 Sep 2026

JWK-001

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
JWK 001, JWK001
Target
VEGF
Action
inhibitors
Mechanism
VEGF inhibitors(Vascular endothelial growth factor inhibitors)
Therapeutic Areas
Cardiovascular DiseasesCongenital DisordersEndocrinology and Metabolic Disease+ [1]
Active Indication
Wet age-related macular degenerationDiabetic macular oedema
Inactive Indication-
Originator Organization
Chengdu Genevector Biotechnology Co. Ltd.Chengdu Genevector Biotechnology Co. Ltd.
Active Organization
Chengdu Genevector Biotechnology Co. Ltd.Chengdu Genevector Biotechnology Co. Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with JWK-001
NCT07776522
/ RecruitingPhase 2IIT
A Phase II Study to Evaluate the Safety and Preliminary Efficacy of Subretinal Administration of JWK001 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
CTR20241792
/ RecruitingPhase 1/2
一项在新生血管性年龄相关性黄斑变性（nAMD）患者中评 价 JWK001 注射液安全性、耐受性和初步有效性的 I/II 期 临床研究
[Translation] A Phase I/II clinical study to evaluate the safety, tolerability and preliminary efficacy of JWK001 injection in patients with neovascular age-related macular degeneration (nAMD)
100 Clinical Results associated with JWK-001
Login to view more data
100 Translational Medicine associated with JWK-001
Login to view more data
100 Patents (Medical) associated with JWK-001
Login to view more data
100 Deals associated with JWK-001
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Wet age-related macular degenerationPhase 2
China
Chengdu Genevector Biotechnology Co. Ltd.Chengdu Genevector Biotechnology Co. Ltd.
21 Jun 2024
Diabetic macular oedemaPhase 2
China
Chengdu Genevector Biotechnology Co. Ltd.Chengdu Genevector Biotechnology Co. Ltd.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free